TR201714149A2 - Ulipristal asetat içeren bir tablet formülasyonu. - Google Patents

Ulipristal asetat içeren bir tablet formülasyonu. Download PDF

Info

Publication number
TR201714149A2
TR201714149A2 TR2017/14149A TR201714149A TR201714149A2 TR 201714149 A2 TR201714149 A2 TR 201714149A2 TR 2017/14149 A TR2017/14149 A TR 2017/14149A TR 201714149 A TR201714149 A TR 201714149A TR 201714149 A2 TR201714149 A2 TR 201714149A2
Authority
TR
Turkey
Prior art keywords
ulipristal acetate
formulation containing
tablet formulation
containing ulipristal
acetate
Prior art date
Application number
TR2017/14149A
Other languages
English (en)
Inventor
Kandemi̇rer Ürün
Çi̇fter Ümi̇t
Kocaoğlan Haluk
Original Assignee
Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/14149A priority Critical patent/TR201714149A2/tr
Priority to PCT/TR2018/050237 priority patent/WO2019059863A1/en
Publication of TR201714149A2 publication Critical patent/TR201714149A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş; cinsel ilişki sonrası acil kontrasepsiyonda kullanılmak üzere birim tablette etken madde Ulipristal Asetat ve en az bir yardımcı madde içeren tablet formunda farmasötik bir formülasyon ile ilgilidir.
TR2017/14149A 2017-09-25 2017-09-25 Ulipristal asetat içeren bir tablet formülasyonu. TR201714149A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/14149A TR201714149A2 (tr) 2017-09-25 2017-09-25 Ulipristal asetat içeren bir tablet formülasyonu.
PCT/TR2018/050237 WO2019059863A1 (en) 2017-09-25 2018-05-16 COMPRESSED FORMULATION COMPRISING ULIPRISTAL ACETATE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/14149A TR201714149A2 (tr) 2017-09-25 2017-09-25 Ulipristal asetat içeren bir tablet formülasyonu.

Publications (1)

Publication Number Publication Date
TR201714149A2 true TR201714149A2 (tr) 2019-04-22

Family

ID=65810490

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/14149A TR201714149A2 (tr) 2017-09-25 2017-09-25 Ulipristal asetat içeren bir tablet formülasyonu.

Country Status (2)

Country Link
TR (1) TR201714149A2 (tr)
WO (1) WO2019059863A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113406230A (zh) * 2021-06-17 2021-09-17 河南泰丰生物科技有限公司 一种醋酸乌利司他固体制剂溶出曲线的测定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006595B (zh) * 2012-12-25 2018-04-06 江苏亚邦爱普森药业有限公司 制备醋酸优力司特片的方法
WO2016001350A1 (en) * 2014-07-03 2016-01-07 Laboratoire Hra-Pharma Method for providing regular contraception

Also Published As

Publication number Publication date
WO2019059863A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
EP4512394A3 (en) Dosage forms and use thereof
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
CL2016001411A1 (es) Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina.
WO2017141104A8 (en) Method for inducing a sustained immune response
JP2015523407A5 (tr)
NI201700173A (es) Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso
MX2020004107A (es) Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas.
MX391191B (es) Composiciones de liberación extendida de onapristona y métodos.
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
CL2016000183A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
BR112023003572A2 (pt) Formulação oral sólida de utidelona
ZA202003904B (en) Drug delivery system
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
MX2023012801A (es) Nueva formulacion.
WO2020022976A3 (en) A formulation comprising dexketoprofen
TR201714150A1 (tr) Kolekalsiferol İçeren Efervesan Tablet Formunda Bir Farmasötik Formülasyon.
CO2019013645A2 (es) Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas
DOP2013000136A (es) Comprimido farmaceutico de liberación controlada para administración oral
CL2012003685A1 (es) Kit farmaceutico que comprende una o mas unidades de envasado que comprenden 21 a 28 unidades de dosificacion activas diarias en que cada una comprende por lo menos 2 mg de drosperidona, sin estrogernos; uso del kit y de una composicion farmaceutica que comprende drosperidona para preparar un medicamento util como anticonceptivo.
TR201722102A2 (tr) Levodropropizin İçeren Farmasötik Bir Ürün
UA97982U (uk) Лікарський засіб седативної дії у вигляді таблеток
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt
PH12019501607A1 (en) Tapentadol nasal composition
AR099971A1 (es) Forma de dosificación unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolítico que comprende darunavir y ritonavir
MX383685B (es) Clonidina y/o derivados de clonidina para uso en la prevención de la lesión de la piel resultante de la radioterapia.